RCM-1

Overview

RCM-1 is a forkhead box M1 (FOXM1) inhibitor with an EC 50 of 0.72 μM in U2OS cells. RCM-1 blocks the nuclear localization and increased the proteasomal degradation of FOXM1 . RCM-1 can be used for asthma and other chronic airway diseases research.

Application

Products | Products > Disease Areas > Asthma | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Lower Respiratory Inflammation | Products > Disease Areas > Respiratory Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > FOXM1 | Products > Signaling Pathways > DNA/RNA Synthesis

Product Information

• Catalog No.: HY-19979
• CAS No.: 339163-65-4
• Molecular Formula: C20H12N2OS4
• Molecular Weight: 424.58
• Purity: 98.56%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Availability: In-stock

Source

Original product source